These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 26349165

  • 1. Nonalcoholic Fatty Liver Disease--The Clinician's Perspective.
    Agrawal S, Duseja A.
    Trop Gastroenterol; 2014; 35(4):212-21. PubMed ID: 26349165
    [Abstract] [Full Text] [Related]

  • 2. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S, Kienbacher C, Halilbasic E, Rechling C, Kazemi-Shirazi L, Hofer H, Munda P, Trauner M.
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [Abstract] [Full Text] [Related]

  • 3. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM, Fu N, Li WC, Kong LL, Yuan XW, Zhang SY, Liu LD, Lu Y, Cui LY.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep 20; 25(9):687-694. PubMed ID: 29108191
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E, Jeske R, Bader AR.
    Am Fam Physician; 2020 Nov 15; 102(10):603-612. PubMed ID: 33179890
    [Abstract] [Full Text] [Related]

  • 5. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Sugimoto K, Inui H, Fukusato T.
    World J Gastroenterol; 2015 Apr 07; 21(13):3777-85. PubMed ID: 25852263
    [Abstract] [Full Text] [Related]

  • 6. Clinical approaches to non-alcoholic fatty liver disease.
    Schwenger KJ, Allard JP.
    World J Gastroenterol; 2014 Feb 21; 20(7):1712-23. PubMed ID: 24587650
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Long MT, Noureddin M, Lim JK.
    Gastroenterology; 2022 Sep 21; 163(3):764-774.e1. PubMed ID: 35842345
    [Abstract] [Full Text] [Related]

  • 9. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Abdalla MA, Akhlaghi S, Sathyapalan T, Sahebkar A.
    Eat Weight Disord; 2022 Mar 21; 27(2):693-700. PubMed ID: 33999371
    [Abstract] [Full Text] [Related]

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Fukusato T.
    World J Gastroenterol; 2014 Nov 14; 20(42):15539-48. PubMed ID: 25400438
    [Abstract] [Full Text] [Related]

  • 11. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A, Sowa JP, Hasenberg T, Canbay A.
    Minerva Gastroenterol Dietol; 2015 Sep 14; 61(3):159-69. PubMed ID: 26080905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapies in non-alcoholic steatohepatitis (NASH).
    Oseini AM, Sanyal AJ.
    Liver Int; 2017 Jan 14; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
    [Abstract] [Full Text] [Related]

  • 14. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T.
    FP Essent; 2015 Aug 14; 435():24-9. PubMed ID: 26280342
    [Abstract] [Full Text] [Related]

  • 15. Liver Disease: Nonalcoholic Fatty Liver Disease.
    Cooper J, Baumgartner K, Smith A, St Louis J.
    FP Essent; 2021 Dec 14; 511():29-35. PubMed ID: 34855339
    [Abstract] [Full Text] [Related]

  • 16. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK, Kim KI, Kim SR.
    Yakugaku Zasshi; 2019 Dec 14; 139(9):1147-1153. PubMed ID: 31474630
    [Abstract] [Full Text] [Related]

  • 17. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
    Corey KE, Rinella ME.
    Dig Dis Sci; 2016 May 14; 61(5):1387-97. PubMed ID: 26942734
    [Abstract] [Full Text] [Related]

  • 18. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.
    Metabolism; 2017 Jun 14; 71():17-32. PubMed ID: 28521870
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A, Wong RJ, Harrison SA.
    Clin Gastroenterol Hepatol; 2015 Nov 14; 13(12):2062-70. PubMed ID: 26226097
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB, Wong RJ, Ahmed A, Harrison SA.
    Dig Dis Sci; 2015 Oct 14; 60(10):3142-8. PubMed ID: 26250831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.